Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide-based evidence from the SURPASS (Researching Tirzepatide in Patients with Type 2 Diabetes for Glycemic Control and Weight Management) trials (SURPASS-1 NCT03954834 and SURPASS-5 NCT04039503) demonstrated dose-dependent, significant weight loss over 40 weeks compared with placebo, along with reductions in BMI and waist circumference [62, 63]
A., Biggins, L
"The reason that doctors start low and increase the tirzepatide dose very slowly is to help your body adjust to the medication
If you have struggled with emotional eating in the past now is a good time to work through these issues and maybe seek the support of a professional
As you titrate up, costs increase because you go through vials faster
US$ 28.46
US$ 22.34
US$ 23.98
US$ 29.90
